Let’s Talk About Lipoedema: Shifting the Paradigm

 Every June, the world turns purple for Lipoedema Awareness Month. Major landmarks light up to bring visibility to a condition that affects up to 11% of women worldwide yet still leaves millions suffering without a proper diagnosis.

Lipoedema is a genetic condition deeply tied to female biology, typically surfacing during major hormonal shifts such as puberty, pregnancy, or perimenopause from age 35 onward.

If you search the internet for lipoedema, you will find endless lists of symptoms. But the clinical conversation is moving much deeper. At a recent Australasian Lymphology Association (ALA) Conference, renowned advanced practice physiotherapist and PhD candidate Helen Eason won the Best Research Focused Presentation award for her work on standardising these essential diagnostic and screening tools [2026 ALA Conference].

A Modern Diagnostic Focus

According to the 2026 Global Delphi Consensus, a major focus of modern research is learning how to accurately distinguish lipoedema from mimicking conditions—like chronic venous insufficiency (varicose veins that cause ankle swelling), lymphedema, or low thyroid function. It also means clearly differentiating it from Ehlers-Danlos Syndrome (EDS) and Dercum’s Disease (Adiposis Dolorosa), a distinct condition characterized by painful, fatty lipoma cysts across the trunk and body.

Research indicates a significant overlap between these separate pathologies; for instance, EDS can be present in 40–70% of individuals with lipoedema. While any of these conditions can co-exist with lipoedema, it is crucial to remember they remain entirely distinct clinical entities.

A New Medical Definition

For decades, lipoedema was mistakenly labelled as simple obesity or fluid retention. Today, international expert consensus has officially reframed lipoedema as a loose connective tissue disorder, rather than just a fat accumulation.

Because of this, medical experts are actively moving away from Body Mass Index (BMI), to the Waist-to-Height Ratio (WHtR) as a much fairer, more accurate tool to assess body fat distribution.

Hormones - History and Hope

• Because Lipoedema is highly sensitive to hormonal milestones such as puberty, pregnancy and menopause, tracking this hormonal timeline also offers great hope for earlier clinical detection and personalized management.

• A groundbreaking research led by Dr. Tara Karnezis at St. Vincent's Institute has successfully mapped how malfunctioning stem cells cause abnormal fat tissue to grow. Building on this discovery, a 2024 family-based study has uncovered nearly 500 candidate genes linked to Lipoedema, offering new hope for clearer diagnostic testing and targeted future treatments.

• The Royal Australian College of General Practitioners (RACGP) has launched its first comprehensive training series on lipoedema, now available to 40,000 GPs across Australia and New Zealand. It has been developed with expert input, including nutritionist Megan Pfeffer and focuses on early recognition and effective care.

Taking Back Control

Here is the most hopeful piece of modern data: lipoedema is not an inevitably progressive disease. Your tissue can remain stable for years. You are not destined to watch your body steadily expland when you have the right support system. 

While specialized surgery is an option for some, conservative management is incredibly powerful. Managing underlying venous insufficiency helps control secondary fluid, while professional support targets low-grade systemic inflammation and eases the mental stress of chronic disease. 

At my clinic, I provide personalised lifestyle and activity advice to help you keep moving safely, paired with customised compression garment prescriptions to control swelling and support fragile tissues. Additionally, I perform LDM (Lymph Drainage Massage) to decrease swelling, actively stimulate fluid movement, reduce inflammation, and alleviate chronic pain.

Your diagnosis is an explanation of what your body is experiencing, not a definition of your potential or your future. Your body is not failing you. With the right answers, you can rewrite your path forward."

Reference

• Australia, L. (n.d.). About lipoedema. Retrieved June 17, 2026, from Lipoedema Australia: https://www.lipoedema.org.au/

• Elettra Fiengo, A. S. (2025, October 12). Lipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology: A Cross-Sectional Observational Study. Journal of Clinical Medicine. doi:10.3390/jcm14207195.

• Helen E Eason 1, S. L. (2025, June 23). Assessment Tools to Quantify the Physical Aspects of Lipedema: A Systematic Review. Lymphatic Research and Biology, 139-159. doi:10.1089/lrb.2024.0102. Epub 2025 Mar 5.

• Karnezis, D. T. (2022, June 6). Steps that lessen the pain. Retrieved June 18, 2026, from St Vincent's Institute Medical Research: https://www.svi.edu.au/news-events/steps-that-lessen-the-pain/

• Philipp Kruppa, R. C.-C. (2026, January 10). Lipedema World Alliance Delphi Consensus-Based Position Paper on the Definition and Management of Lipedema: Results from the 2023 Lipedema World Congress in Potsdam. doi:https://doi.org/10.1038/s41467-025-68232-z

• RACGP. (2026, June). Retrieved June 19, 2026, from Check RACGP CPD solutions: https://www.racgp.org.au/check/check-issues/2025-1/lipoedema

• UK, P. P. (2026). Lipoedema as a Connective Tissue Disorder: The 2026 PhysioPod® UK Independent Review. Retrieved June 19, 2026, from Physio Pod UK: https://www.physiopod.co.uk/lipoedema-a-connective-tissue-disorder

# LipoedemaAwareness#LipoedemaAwarenessMonth#LipoedemaWorldAlliance#LetLetTalkAboutLipoedema#TurnWorldPurpleCommunity & SupportNetwork#LipoedemaSisters